Background:Painful dysfunctional shoulders with irreparable rotator cuff tears (IRCTs)
in active patients are a challenge. Arthroscopic superior capsular
reconstruction (ASCR) is a new treatment option originally described using a
fascia lata autograft harvested through an open approach. However, concerns
about donor site morbidity have discouraged surgeons from using this type of
graft.Hypothesis:ASCR using a minimally invasive harvested fascia lata autograft produces good
6-month and 2-year shoulder outcomes in IRCTs, with low-impact thigh
morbidity at 2 years.Study Design:Case series; Level of evidence, 4.Methods:From 2015 to 2016, a total of 22 consecutive patients (mean age, 64.8 ± 8.6
years) with chronic IRCTs (Hamada grade 1-2; Goutallier cumulative grade ≥3;
Patte stage 1: 2 patients; Patte stage 2: 6 patients; Patte stage 3: 14
patients) underwent ASCR using a minimally invasive harvested fascia lata
autograft. All patients completed preoperative and 6-month evaluations
consisting of the Simple Shoulder Test (SST), subjective shoulder value
(SSV), Constant score (CS), range of motion (ROM), acromiohumeral interval
(AHI), and magnetic resonance imaging. Twenty-one patients completed the
2-year shoulder and donor site morbidity assessments.Results:The mean active ROMs improved significantly (P < .001):
elevation, from 74.8° ± 55.5° to 104.5° ± 41.9° (6 months) and 143.8° ±
31.7° (2 years); abduction, from 53.2° ± 43.3° to 86.6° ± 32.9° (6 months)
and 120.7° ± 37.7° (2 years); external rotation, from 13.2° ± 18.4° to 27.0°
± 16.1° (6 months) and 35.6° ± 17.3° (2 years); and internal rotation, from
1.2 ± 1.5 points to 2.6 ± 1.5 points (6 months) and 3.8 ± 1.2 points (2
years). The mean functional shoulder scores improved significantly
(P < .001): SST, from 2.1 ± 2.9 to 6.8 ± 3.5 (6
months) and 8.6 ± 3.5 (2 years); SSV, from 33.0% ± 17.4% to 55.7% ± 25.6% (6
months) and 70.0% ± 23.0% (2 years); CS, from 17.5 ± 13.4 to 42.5 ± 14.9 (6
months) and 64.9 ± 18.0 (2 years). The mean shoulder abduction strength
improved significantly (P < .001) from 0.0 to 1.1 ± 1.4
kg (6 months) and 2.8 ± 2.6 kg (2 years). The mean AHI improved from 6.4 ±
3.3 mm to 8.0 ± 2.5 mm (6 months) and decreased to 7.1 ± 2.5 mm (2 years).
This 0.7 ± 1.5–mm overall decrease was statistically significant
(P = .042). At 6 months, 20 of 22 patients (90.9%) had
no graft tears. At 2 years, 12 of 21 patients (57.1%) were bothered by their
harvested thigh, 16 (76.2%) noticed donor site changes, 16 (76.2%)
considered that the shoulder surgery’s end result compensated for the
thigh’s changes, and 18 (85.7%) would undergo the same surgery again.Conclusion:ASCR using a minimally invasive harvested fascia lata autograft produced good
6-month and 2-year shoulder outcomes in IRCTs, with low-impact thigh
morbidity at 2 years.